- Trials with a EudraCT protocol (2,084)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (79)
2,084 result(s) found for: Side effects.
Displaying page 6 of 105.
EudraCT Number: 2012-002618-38 | Sponsor Protocol Number: AnesBar01 | Start Date*: 2013-10-15 | ||||||||||||||||
Sponsor Name: | ||||||||||||||||||
Full Title: Does preperitoneal local anesthesia in laparoscopic gastric bypass surgery reduce postoperative pain and opioid consumption? | ||||||||||||||||||
Medical condition: Postoperative pain | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: NL (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2022-001582-12 | Sponsor Protocol Number: 4 | Start Date*: 2023-03-01 |
Sponsor Name:Consorcio Centro de Investigacion Biomedica en Red (CIBER) | ||
Full Title: Open, multicenter, randomized clinical trial to evaluate the efficacy and safety of aripiprazole vs paliperidone / risperidone using multi-omics data in patients with a first psychotic episode. | ||
Medical condition: First episode SZ-spectrum individuals | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2017-001284-20 | Sponsor Protocol Number: BIOGIO | Start Date*: 2017-07-05 |
Sponsor Name:Erasmus MC Cancer Institute | ||
Full Title: The effects of the proton pump inhibitor esomeprazole on the bioavailability of afatinib (Giotrif®) in patients with non-small cell lung cancer (NSCLC) 'the BIO-GIO study' | ||
Medical condition: Non small cell lung cancer | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2015-005784-17 | Sponsor Protocol Number: REGORA | Start Date*: 2016-05-19 |
Sponsor Name:Erasmus MC cancer institute | ||
Full Title: The effects of the proton pump inhibitor esomeprazole on the bioavailability of regorafenib in patients with a metastatic colorectal cancer (mCRC) or gastrointestinal stromal tumour (GIST). | ||
Medical condition: GIST and mCRC patients | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2019-002826-58 | Sponsor Protocol Number: 1 | Start Date*: 2020-02-05 | |||||||||||
Sponsor Name:Rijnstate Hospital, Arnhem | |||||||||||||
Full Title: The effects of enoximone in acute exacerbation COPD: a pilot study | |||||||||||||
Medical condition: Acute exacerbation of COPD | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-003882-17 | Sponsor Protocol Number: MKM | Start Date*: 2013-05-06 |
Sponsor Name:Charité Universitaetsmedizin Berlin | ||
Full Title: Effects of modafinil, caffeine and methylphenidate on functional brain activity and cognitive performance in healthy subjects: a randomized, placebo-controlled, double-blind fMRI study. | ||
Medical condition: healthy volunteers | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2017-001915-35 | Sponsor Protocol Number: 08052017 | Start Date*: 2017-09-15 |
Sponsor Name:Medical University of Graz | ||
Full Title: GLUCOCORTICOID HIGH-DOSE VS. REPLACEMENT IN IMMUNE CHECKPOINT INHIBITOR ASSOCIATED HYPOPHYSITIS: AN OPEN, RANDOMIZED PILOT STUDY | ||
Medical condition: Immune regulatory antibodies (e.g. ipilimumab, pembrolizumab and nivolumab) inhibiting immunological checkpoints are increasingly used to treat various oncological entities. Potential side effects ... | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2012-002622-75 | Sponsor Protocol Number: 2013 | Start Date*: 2013-05-21 | ||||||||||||||||
Sponsor Name:Vibeke Hjortdal | ||||||||||||||||||
Full Title: Lymphatic dysfunction as a cause of calcium channel blocker oedema | ||||||||||||||||||
Medical condition: Fluid accumulation in the leg associated with calcium channel blocker therapy. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male | |||||||||||||||||
Trial protocol: DK (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-001541-18 | Sponsor Protocol Number: T3RIS22007 | Start Date*: 2007-10-08 | |||||||||||
Sponsor Name:Institute of Psychophysiology and Rehabilitation (IRP) of the Kaunas University of Medicine | |||||||||||||
Full Title: Triiodothyronine as an adjunct in treatment of acute schizophrenia | |||||||||||||
Medical condition: Acute Schizoprenia episode | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: LT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-000848-95 | Sponsor Protocol Number: 020119 | Start Date*: 2019-07-29 | |||||||||||
Sponsor Name:Dansk Hovedpine Center, Neurologisk Klinik, Rigshospitalet - Glostrup | |||||||||||||
Full Title: A Placebo-Controlled, Double-Blind, Randomized, Proof-of-Concept Study to Evaluate the Efficacy and Tolerability of Erenumab in Patients with Trigeminal Neuralgia | |||||||||||||
Medical condition: Trigeminal neuralgia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-000779-33 | Sponsor Protocol Number: UMCN-AKF-18.01 | Start Date*: 2018-11-05 | ||||||||||||||||
Sponsor Name:Radboud University Medical Center | ||||||||||||||||||
Full Title: Effect of a reduced dose on cognitive side effects of enzalutamide in frail (m)CRPC patients | ||||||||||||||||||
Medical condition: (Metastatic) Castration Resistant Prostate Cancer (mCRPC) | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male | |||||||||||||||||
Trial protocol: NL (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2020-004872-17 | Sponsor Protocol Number: IC2020-04 | Start Date*: 2021-03-18 | ||||||||||||||||
Sponsor Name:INSTITUT CURIE | ||||||||||||||||||
Full Title: A Double-blind Randomized non-inferiority Trial of erector spinae block (ESP) versus paravertebral block (PVB) before Breast Cancer Surgery: Effects on acute Postoperative Pain | ||||||||||||||||||
Medical condition: Nervous Block erector spinae plane (ESP) or paravertebral block (PVB) preoperatively in women with breast adenocarcinoma without metastasis or breast in situ adenocarcinoma to by treated either by... | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Female | |||||||||||||||||
Trial protocol: FR (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-001951-36 | Sponsor Protocol Number: HTG-Oxy1 | Start Date*: 2006-05-15 |
Sponsor Name:Medical University of Vienna | ||
Full Title: Perioperative Analgesie in der Gefäßchirurgie | ||
Medical condition: peripheral vascular disease, inclusion criteria: elective vascular surgery, age 30 to100years; male and female; exclusion Criteria: amaurosis, insufficient language skills, permanent opioid medicat... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2019-001539-29 | Sponsor Protocol Number: alsbjerg1 | Start Date*: 2019-10-11 | |||||||||||
Sponsor Name:The Fertility Clinic, Skive Regional Hospital | |||||||||||||
Full Title: Optimizing serum progesterone level during luteal phase in hormone replacement therapy frozen embryo transfer (HRT-FET) cycle – interventional and observational trial | |||||||||||||
Medical condition: Infertility | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-023538-22 | Sponsor Protocol Number: LY107 | Start Date*: 2011-08-30 |
Sponsor Name:Lipid Pharmaceuticals | ||
Full Title: Lýsi sem hægðalyf fyrir börn | ||
Medical condition: The primary objective of this trial is to investigate the laxative effect of Lysisstílar (Free Fatty Acids suppositories) as compared to Klyx. Participants are children aged 1 year old to 17 year... | ||
Disease: | ||
Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: IS (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2006-002450-30 | Sponsor Protocol Number: AcadMed CTU03/05 | Start Date*: 2006-07-12 |
Sponsor Name:Hull and East Yorkshire Hospitals Trust | ||
Full Title: An Open label Study to Compare Systemic Side Effects of High Dose Fluticasone/Salmeterol with that of High Dose Ciclesonide /Salmeterol in Symptomatic Asthmatics | ||
Medical condition: Chronic asthma | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2011-000076-33 | Sponsor Protocol Number: UMCNONCO201007 | Start Date*: 2011-11-15 |
Sponsor Name:University Medical Centre Nijmegen | ||
Full Title: Efficacy and Cost Efficacy of Prophylactic treatment with Antibiotics during concomitant chemoradiotherapy in patients with locally advanced head and neck cancer to prevent Aspiration Pneumonia. | ||
Medical condition: Patients with LAHNC which will be treated with chemoradiotherapy, as primary treatment or as postoperative treatment | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2015-002435-18 | Sponsor Protocol Number: Diclometh-2015 | Start Date*: 2015-07-27 | |||||||||||
Sponsor Name:Aalborg University Hospital | |||||||||||||
Full Title: An Evidence Based, Translational, Cross-Over, Randomized, Double-Blind, Placebo Controlled Study to Evaluate Effectiveness of Topically applied Combination of Diclofenac and Methadone Gel (Diclome... | |||||||||||||
Medical condition: Healthy volunteers | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-004172-30 | Sponsor Protocol Number: PREPARE | Start Date*: 2021-10-13 |
Sponsor Name:Charité – Universitätsmedizin Berlin | ||
Full Title: Prevention of paclitaxel-related neurological side effects with lithium – a randomized, double-blind, placebo-controlled, explorative proof-of-concept phase II clinical trial to counteract chemothe... | ||
Medical condition: Breast cancer patients scheduled for treatment with paclitaxel chemotherapy | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Female | |
Trial protocol: DE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2021-003929-30 | Sponsor Protocol Number: 1 | Start Date*: 2022-10-14 |
Sponsor Name:Ligalli BV | ||
Full Title: INFLUENCE OF OXYBUTYNIN - MEDRING LIGALLI ON OVERACTIVE BLADDER SYMPTOMS IN WOMEN | ||
Medical condition: urinary urge incontinence | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Female | |
Trial protocol: BE (Completed) | ||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
